General description
INN
Pembrolizumab
ATC codes
Medicine type
Biological agent
EML status history
Application rejected in 2019
(TRS
1021)
for
Other specified malignant neoplasms of bronchus or lung
Changed in 2019
(TRS
1021)
for
Melanoma of skin
Therapeutic equivalent for
Wikipedia
DrugBank
Recommendations
Section
Immunomodulators
- Parenteral > General injections > IV: 50 mg powder for injection